FAM114A1 and fibrosis: We used a global Fam114a1-KO mouse model to demonstrate that deletion of FAM114A1 antagonizes pathological cardiac remodeling, including cardiac fibrosis, CM hypertrophy, and inflammation in vivo using Ang II and MI models.